Literature DB >> 7547191

In vivo 31P MRS: absolute concentrations, signal-to-noise and prior knowledge.

A van den Boogaart1, F A Howe, L M Rodrigues, M Stubbs, J R Griffiths.   

Abstract

Absolute metabolite concentrations have been estimated for nucleoside triphosphate and P(i) from in vivo 31P MR measurements using ISIS localization in a rat tumour model, and the results have been compared to those obtained from acid extracts of the tumours. The aim of the experiment was to assess the performance of four different spectral analysis techniques used for absolute quantitation. The spectral analysis techniques used were two frequency domain methods (peak area integration and Lorentzian fitting--FITSPEC) and two time domain methods (VARPRO and HLSVD). The spectra were acquired in blocks so that the degradation in performance of the four spectral analysis methods with decreasing signal-to-noise ratio (SNR) could be compared and referenced. This and the inclusion of a sophisticated method incorporating prior knowledge yields a more realistic and comprehensive protocol than previously published comparisons. The results suggest that VARPRO is the method of choice for quantitative analysis of tumour 31P MR spectra, giving the most reliable results at low SNR.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7547191     DOI: 10.1002/nbm.1940080207

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  10 in total

1.  Response of hepatoma 9618a and normal liver to host carbogen and carbon monoxide breathing.

Authors:  S P Robinson; L M Rodrigues; J R Griffiths; M Stubbs
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

2.  Noninvasive measurement of gene expression in skeletal muscle.

Authors:  G Walter; E R Barton; H L Sweeney
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  31P NMR studies of human soleus and gastrocnemius show differences in the J gamma beta coupling constant of ATP and in intracellular free magnesium.

Authors:  S Widmaier; T Hoess; W I Jung; A Staubert; G F Dietze; O Lutz
Journal:  MAGMA       Date:  1996-03       Impact factor: 2.310

4.  Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivo.

Authors:  Vassiliki Kostourou; Helen Troy; Joanne F Murray; Elizabeth R Cullis; Guy St J Whitley; John R Griffiths; Simon P Robinson
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

5.  Noninvasive characterization of neonatal adipose tissue by 13C magnetic resonance spectroscopy.

Authors:  E L Thomas; J D Hanrahan; M Ala-Korpela; G Jenkinson; D Azzopardi; R A Iles; J D Bell
Journal:  Lipids       Date:  1997-06       Impact factor: 1.880

6.  In vivo detection of ifosfamide by 31P-MRS in rat tumours: increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas.

Authors:  L M Rodrigues; R J Maxwell; P M McSheehy; C R Pinkerton; S P Robinson; M Stubbs; J R Griffiths
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  The effect of hypoxia and hyperoxia on nucleoside triphosphate/inorganic phosphate, pO2 and radiation response in an experimental tumour model.

Authors:  M Nordsmark; R J Maxwell; M R Horsman; S M Bentzen; J Overgaard
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Effects of nicotinamide and carbogen on tumour oxygenation, blood flow, energetics and blood glucose levels.

Authors:  S P Robinson; F A Howe; M Stubbs; J R Griffiths
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

9.  31P-magnetic resonance spectroscopy and 2H-magnetic resonance imaging studies of a panel of early-generation transplanted murine tumour models.

Authors:  S P Robinson; A van den Boogaart; R J Maxwell; J R Griffiths; E Hamilton; J C Waterton
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

10.  Correlation between 5-fluorouracil metabolism and treatment response in two variants of C26 murine colon carcinoma.

Authors:  Y J L Kamm; G J Peters; W E Hull; C J A Punt; A Heerschap
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.